147 related articles for article (PubMed ID: 25353288)
21. Re: Does discontinuous involvement of a prostatic needle biopsy core by adenocarcinoma correlate with a large tumor focus at radical prostatectomy?
Taneja SS
J Urol; 2015 Apr; 193(4):1252. PubMed ID: 25890512
[No Abstract] [Full Text] [Related]
22. Adenocarcinoma of the prostate with Gleason score 9-10 on core biopsy: correlation with findings at radical prostatectomy and prognosis.
Ellis CL; Partin AW; Han M; Epstein JI
J Urol; 2013 Dec; 190(6):2068-73. PubMed ID: 23727307
[TBL] [Abstract][Full Text] [Related]
23. Value of transition zone biopsy in active surveillance of prostate cancer.
Wang CC; Carter HB; Epstein JI
J Urol; 2014 Jun; 191(6):1755-9. PubMed ID: 24316092
[TBL] [Abstract][Full Text] [Related]
24. Aberrant diffuse expression of p63 in adenocarcinoma of the prostate on needle biopsy and radical prostatectomy: report of 21 cases.
Osunkoya AO; Hansel DE; Sun X; Netto GJ; Epstein JI
Am J Surg Pathol; 2008 Mar; 32(3):461-7. PubMed ID: 18300803
[TBL] [Abstract][Full Text] [Related]
25. Intraductal carcinoma of the prostate without invasive carcinoma on needle biopsy: emphasis on radical prostatectomy findings.
Robinson BD; Epstein JI
J Urol; 2010 Oct; 184(4):1328-33. PubMed ID: 20723921
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological features of prostate cancers detected after an initial diagnosis of 'atypical glands suspicious for cancer'.
Zhou M; Magi-Galluzzi C
Pathology; 2010 Jun; 42(4):334-8. PubMed ID: 20438405
[TBL] [Abstract][Full Text] [Related]
27. The diagnosis and reporting of adenocarcinoma of the prostate in core needle biopsy specimens.
Epstein JI
Cancer; 1996 Jul; 78(2):350-6. PubMed ID: 8674016
[TBL] [Abstract][Full Text] [Related]
28. The value of mandatory second opinion pathology review of prostate needle biopsy interpretation before radical prostatectomy.
Brimo F; Schultz L; Epstein JI
J Urol; 2010 Jul; 184(1):126-30. PubMed ID: 20478583
[TBL] [Abstract][Full Text] [Related]
29. Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate.
Arora R; Koch MO; Eble JN; Ulbright TM; Li L; Cheng L
Cancer; 2004 Jun; 100(11):2362-6. PubMed ID: 15160339
[TBL] [Abstract][Full Text] [Related]
30. A contemporary update on pathology reporting for prostate cancer: biopsy and radical prostatectomy specimens.
Fine SW; Amin MB; Berney DM; Bjartell A; Egevad L; Epstein JI; Humphrey PA; Magi-Galluzzi C; Montironi R; Stief C
Eur Urol; 2012 Jul; 62(1):20-39. PubMed ID: 22421083
[TBL] [Abstract][Full Text] [Related]
31. Prostate needle biopsy examination by means of virtual microscopy.
Chargari C; Comperat E; Magné N; Védrine L; Houlgatte A; Egevad L; Camparo P
Pathol Res Pract; 2011 Jun; 207(6):366-9. PubMed ID: 21570778
[TBL] [Abstract][Full Text] [Related]
32. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.
King CR; McNeal JE; Gill H; Presti JC
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):386-91. PubMed ID: 15145152
[TBL] [Abstract][Full Text] [Related]
33. Multiple prostate cancer cores with different Gleason grades submitted in the same specimen container without specific site designation: should each core be assigned an individual Gleason score?
Kunju LP; Daignault S; Wei JT; Shah RB
Hum Pathol; 2009 Apr; 40(4):558-64. PubMed ID: 19144380
[TBL] [Abstract][Full Text] [Related]
34. Re: should intervening benign tissue be included in the measurement of discontinuous foci of cancer on prostate needle biopsy? Correlation with radical prostatectomy findings.
Van der Kwast TH
Eur Urol; 2012 Jan; 61(1):220. PubMed ID: 22122873
[No Abstract] [Full Text] [Related]
35. Adenocarcinoma on needle prostatic biopsies: does reactive stroma predicts biochemical recurrence in patients following radical prostatectomy?
Billis A; Meirelles L; Freitas LL; Polidoro AS; Fernandes HA; Padilha MM; Magna LA; Reis LO; Ferreira U
Int Braz J Urol; 2013; 39(3):320-7. PubMed ID: 23849565
[TBL] [Abstract][Full Text] [Related]
36. Gleason histologic grading in prostatic carcinoma. Correlation of 18-gauge core biopsy with prostatectomy.
Spires SE; Cibull ML; Wood DP; Miller S; Spires SM; Banks ER
Arch Pathol Lab Med; 1994 Jul; 118(7):705-8. PubMed ID: 8024404
[TBL] [Abstract][Full Text] [Related]
37. Preoperative prediction of small volume cancer (less than 0.5 ml) in radical prostatectomy specimens.
Cheng L; Poulos CK; Pan CX; Jones TD; Daggy JK; Eble JN; Koch MO
J Urol; 2005 Sep; 174(3):898-902. PubMed ID: 16093983
[TBL] [Abstract][Full Text] [Related]
38. Prediction of potentially insignificant prostate cancer in men undergoing radical prostatectomy for clinically organ-confined disease.
Miyake H; Sakai I; Harada K; Hara I; Eto H
Int J Urol; 2005 Mar; 12(3):270-4. PubMed ID: 15828954
[TBL] [Abstract][Full Text] [Related]
39. Prediction of pathological stages before prostatectomy in prostate cancer patients: analysis of 12 systematic prostate needle biopsy specimens.
Park EA; Lee HJ; Kim KG; Kim SH; Lee SE; Choe GY
Int J Urol; 2007 Aug; 14(8):704-8. PubMed ID: 17681059
[TBL] [Abstract][Full Text] [Related]
40. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies.
Stewart CS; Leibovich BC; Weaver AL; Lieber MM
J Urol; 2001 Jul; 166(1):86-91; discussion 91-2. PubMed ID: 11435830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
